China SXT Pharmaceuticals, Inc. (SXTC) Operating cash flow 2017–2026
China SXT Pharmaceuticals, Inc. (SXTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.0MFY2026 · since FY2017: $293,042 → -$4.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.0M | -71.3% |
| FY2025 | -$2.3M | -21.6% |
| FY2024 | -$1.9M | -2287.5% |
| FY2023 | -$80,757 | -130.1% |
| FY2022 | $268,293 | +120.4% |
| FY2021 | -$1.3M | -240.9% |
| FY2020 | $934,247 | +290.6% |
| FY2019 | $239,192 | -87.5% |
| FY2018 | $1.9M | +555.3% |
| FY2017 | $293,042 | — |
Source: SEC XBRL filings · For reference only · Not investment advice